Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 49 points (0.3%) at 16,411 as of Monday, April 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,415 issues advancing vs. 1,576 declining with 152 unchanged. The Financial sector currently sits down 0.1% versus the S&P 500, which is unchanged. On the negative front, top decliners within the sector include CNA Financial ( CNA), down 4.5%, Royal Bank of Scotland Group (The ( RBS), down 2.6%, Franklin Resources ( BEN), down 2.1%, Blackstone Group ( BX), down 1.7% and SunTrust Banks ( STI), down 1.5%. Top gainers within the sector include Northstar Realty Finance ( NRF), up 8.9%, HCP ( HCP), up 1.6%, Chubb ( CB), up 1.2% and Visa ( V), up 0.9%. TheStreet would like to highlight 3 stocks pushing the sector lower today: 3. MetLife ( MET) is one of the companies pushing the Financial sector lower today. As of noon trading, MetLife is down $0.37 (-0.7%) to $50.72 on average volume. Thus far, 3.1 million shares of MetLife exchanged hands as compared to its average daily volume of 6.3 million shares. The stock has ranged in price between $50.28-$51.52 after having opened the day at $51.46 as compared to the previous trading day's close of $51.09. MetLife, Inc., through its subsidiaries, provides insurance, annuities, and employee benefit programs in the United States, Japan, Latin America, Asia, Europe, and the Middle East. MetLife has a market cap of $58.5 billion and is part of the insurance industry. The company has a P/E ratio of 18.0, above the S&P 500 P/E ratio of 17.7. Shares are down 5.2% year-to-date as of the close of trading on Friday. Currently there are 13 analysts that rate MetLife a buy, no analysts rate it a sell, and 2 rate it a hold. TheStreet Ratings rates MetLife as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, good cash flow from operations, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full MetLife Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.